ALLMedicine™ Anaplastic Oligodendroglioma Center
Research & Reviews 129 results
https://doi.org/10.1097/SCS.0000000000008754
The Journal of Craniofacial Surgery; Klein HJ, Giovanoli P et. al.
Jul 30th, 2022 - Major complex cranial defects may be challenging for the reconstructive microsurgeon. Affected patients often present with impaired soft tissues including dura exposure or fistulas. The lacking structural bony support may cause severe neurological...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302255
Medicine Xu J, Xu FP et. al.
Jul 23rd, 2022 - To investigate the correlations between mutations in the telomerase reverse transcriptase (TERT) promoter and isocitrate dehydrogenase (IDH) 1 and 2 mutations or 1p/19q deletion in human gliomas. TERT promoter gene and IDH gene mutations in 110 gl...
https://clinicaltrials.gov/ct2/show/NCT03434262
Apr 4th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...
https://doi.org/10.3171/2022.1.JNS212562
Journal of Neurosurgery; Strickland BA, Wedemeyer M et. al.
Mar 19th, 2022 - 5-Aminolevulinic acid (5-ALA)-enhanced fluorescence-guided resection of high-grade glioma (HGG) using microscopic blue light visualization offers the ability to improve extent of resection (EOR); however, few descriptions of HGG resection performe...
https://clinicaltrials.gov/ct2/show/NCT00303849
Mar 17th, 2022 - PRIMARY OBJECTIVES: I. To evaluate toxicity and estimate the maximum tolerated dose (MTD) of melphalan (intra-arterially [i.a.]) administered in conjunction with carboplatin (i.a.) and etoposide phosphate (intravenously [i.v.]) undergoing BBBD, in...
Guidelines 1 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124889
Journal of the National Comprehensive Cancer Network : JN... Nabors LB, Ammirati M et. al.
Sep 14th, 2013 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemothera...
Clinicaltrials.gov 23 results
https://clinicaltrials.gov/ct2/show/NCT03434262
Apr 4th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...
https://clinicaltrials.gov/ct2/show/NCT00303849
Mar 17th, 2022 - PRIMARY OBJECTIVES: I. To evaluate toxicity and estimate the maximum tolerated dose (MTD) of melphalan (intra-arterially [i.a.]) administered in conjunction with carboplatin (i.a.) and etoposide phosphate (intravenously [i.v.]) undergoing BBBD, in...
https://clinicaltrials.gov/ct2/show/NCT00588523
Oct 8th, 2021 - The purpose of this study is to see how effective treatment of high doses of chemotherapy is for your tumor. We will also be looking at the side effects and risks of this treatment. You will receive very high doses of chemotherapy. High doses of c...
https://clinicaltrials.gov/ct2/show/NCT00003372
Apr 8th, 2020 - OBJECTIVES: I. Determine the efficacy of topotecan in patients with recurrent anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma. II. Determine the qualitative and quantitative toxicity of topotecan in this patient population on thi...
https://clinicaltrials.gov/ct2/show/NCT00400816
Sep 18th, 2018 - OBJECTIVES: Determine progression-free survival of patients with newly diagnosed anaplastic oligodendroglioma (AO) or mixed oligoastrocytoma (MOA) treated with temozolomide. Determine the response rate in these patients. Assess the quality of life...
News 3 results
https://www.onclive.com/publications/obtn/2012/july-2012/plenary-sunday-at-asco
Jul 26th, 2012 - Andrew L. Pecora, MD Editor-in-Chief Oncology & Biotech News Chief Innovations Officer, Professor, and Vice President of Cancer Services John Theurer Cancer Center at Hackensack University Medical Center I am sure any of us can think of many other...
https://www.medscape.com/viewarticle/559493
Case Report A thunderclap headache is a severe headache with sudden onset similar to a clap of thunder, with a maximum intensity within 1 minute. The primary types (thunderclap, cough, exertional, and sexual) can recur intermittently and are gener...
https://www.medscape.com/viewarticle/559493_2
Discussion Although Day and Raskin[1] initially coined the term thunderclap headache to refer to the headache associated with an unruptured aneurysm, the most common secondary cause is subarachnoid hemorrhage. Other secondary causes include cerebr...